$4.62
0.317.19%
At close: -
$4.94
0.326.93%
After Hours: 9:13 AM EDT
Comments
Loading...
Eupraxia Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:EPRX | Benzinga
Eupraxia Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Eupraxia Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Rodman & Renshaw
1calculated from analyst ratings
Analyst Ratings for Eupraxia Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2025 | Buy Now | — | HC Wainwright & Co. | Brandon Folkes45% | → $12 | Initiates | → Buy | Get Alert |
| 11/14/2024 | Buy Now | — | Rodman & Renshaw | Brandon Folkes45% | → $9 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Eupraxia Pharmaceuticals (EPRX) stock?
The latest price target for Eupraxia Pharmaceuticals (NASDAQ:EPRX) was reported by HC Wainwright & Co. on June 26, 2025. The analyst firm set a price target for $12.00 expecting EPRX to rise to within 12 months (a possible 142.91% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eupraxia Pharmaceuticals (EPRX)?
The latest analyst rating for Eupraxia Pharmaceuticals (NASDAQ:EPRX) was provided by HC Wainwright & Co., and Eupraxia Pharmaceuticals initiated their buy rating.
When was the last upgrade for Eupraxia Pharmaceuticals (EPRX)?
There is no last upgrade for Eupraxia Pharmaceuticals
When was the last downgrade for Eupraxia Pharmaceuticals (EPRX)?
There is no last downgrade for Eupraxia Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eupraxia Pharmaceuticals (EPRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eupraxia Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eupraxia Pharmaceuticals was filed on June 26, 2025 so you should expect the next rating to be made available sometime around June 26, 2026.
Is the Analyst Rating Eupraxia Pharmaceuticals (EPRX) correct?
While ratings are subjective and will change, the latest Eupraxia Pharmaceuticals (EPRX) rating was a initiated with a price target of $0.00 to $12.00. The current price Eupraxia Pharmaceuticals (EPRX) is trading at is $4.94, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
